Cargando…
Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab
Given the increasing use of combination therapy with multiple monoclonal antibodies (mAbs), there is a clinical need for multiplexing assays. For the frequently co-administered anti-human epidermal growth factor receptor 2 (HER2) mAbs trastuzumab and pertuzumab, we developed a high-throughput and ro...
Autores principales: | Schokker, Sandor, Fusetti, Fabrizia, Bonardi, Francesco, Molenaar, Remco J., Mathôt, Ron A.A., van Laarhoven, Hanneke W.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531571/ https://www.ncbi.nlm.nih.gov/pubmed/32744170 http://dx.doi.org/10.1080/19420862.2020.1795492 |
Ejemplares similares
-
Stoichiometric Quantification of Akt Phosphorylation Using LC-MS/MS
por: Atrih, Abdelmadjid, et al.
Publicado: (2009) -
LC-MS/MS Validation Analysis of Trastuzumab Using dSIL Approach for Evaluating Pharmacokinetics
por: Budhraja, Rohit H., et al.
Publicado: (2016) -
Pipelines and Systems for Threshold-Avoiding Quantification
of LC–MS/MS Data
por: Sánchez Brotons, Alejandro, et al.
Publicado: (2021) -
Estimation of measurement uncertainty for the quantification of protein by ID-LC–MS/MS
por: Beasley-Green, Ashley, et al.
Publicado: (2023) -
Quantification of cGMP in human plasma by isotope dilution LC-MS/MS
por: Martens-Lobenhoffer, Jens, et al.
Publicado: (2009)